Influences of the PPAR alpha-L162V polymorphism on plasma HDL(2)-cholesterol response of abdominally obese men treated with gemfibrozil (Q44097757)

From Wikidata

Revision as of 08:17, 17 July 2024 by Twofivesixbot (talk | contribs) (‎Updated Item: rm P2888 pointing to scigraph.springernature.com; site discontinued and merely duplicating DOI)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published in July 2002

Language	Label	Description	Also known as
English	Influences of the PPAR alpha-L162V polymorphism on plasma HDL(2)-cholesterol response of abdominally obese men treated with gemfibrozil	scientific article published in July 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Influences of the PPAR alpha-L162V polymorphism on plasma HDL(2)-cholesterol response of abdominally obese men treated with gemfibrozil (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

0 references

0 references

Marie-Claude Vohl

object named as

Marie-Claude Vohl

8

0 references

Jean-Pierre Després

7

object named as

Jean-Pierre Després

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Yohan Bossé

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Agnès Pascot

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Martine Dumont

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Martin Brochu

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Denis Prud'homme

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Jean Bergeron

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Genetics in Medicine

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

311-315

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

Mechanism of action of fibrates on lipid and lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants.

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Experience from the Helsinki Heart Study

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

21 January 2018

Identifiers

10.1097/00125817-200207000-00010

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44097757&oldid=2206433897"